Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia

نویسندگان

چکیده

Abstract Background Acute promyelocytic leukemia (APL) is a special type of acute myeloid Thrombosis at increased risk complication in patients with this disease. However, the factors thrombosis related to Chinese APL are not fully understood. Methods In study, clinical and laboratory data 44 consecutively were collected analyzed. Results One arterial 6 venous occurred patients, including 22 males females, median age years (range from 18 74 years). The ratio male female gender, age, white blood cell count, hemoglobin, platelets, disease stratification, CD2, Khorana score, differentiation syndrome (DS) gene mutation prognosis APL, DNMT3A, TET2, IDH1, IDH2, NRAS ASXL1 two groups without statistically significant. detection rate PAI-1 genotype 4G4G was 71.4% (5/7) 7 thrombosis, while 37 8.1% (3/37). differences between WT-1 ( P = 0.01), 0.0009), bcr3 0.027), CD15 0.005), FLT3-ITD 0.0008) Using multivariate analysis, 0.043), 0.009), 0.043) FLT3/ITD 0.013), respectively. Conclusion Our results suggested type, CD15, mutations excluding IDH1/2, thrombotic events patients.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Open issues on bleeding and thrombosis in acute promyelocytic leukemia.

Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia characterized by a specific genetic alteration, affecting the retinoic acid receptor-alpha (RAR-alpha), and leading to the accumulation of the promyelocytic blasts in the bone marrow and blood which is frequently associated with a life-threatening consumptive coagulopathy. The body of biological information on AP...

متن کامل

Acute myeloid leukemia and acute promyelocytic leukemia.

The therapeutic approach to the patient with acute myeloid leukemia (AML) currently evolves toward new frontiers. This is particularly apparent from the entree of high-throughput diagnostic technologies and the identification of prognostic and therapeutic targets, the introduction of therapies in genetically defined subgroups of AML, as well as the influx of investigational approaches and novel...

متن کامل

Acute myeloid leukemia pretreated with filgrastim mimicking acute promyelocytic leukemia.

A 66-year-old man with a history of hepatitis C virus and liver transplantation presented to the emergency department for shortness of breath. He had received weekly filgrastim for chronic neutropenia, and immediately before admission he had received 3 days of filgrastim and 1 day of pegfilgrastim. A hemogram showed a white blood cell count of 4.54 K/mL with 23% blastic cells. Emergent bone mar...

متن کامل

Acute promyelocytic leukemia?

Briefly, the important clinical findings were as follows: A 10 year old white girl, acutely ill, febrile and showing disseminated skin purpura. There was no visceromegaly. The disease had apparently started 3 weeks before, with epistaxis and other purpuric manifestations. Laboratory findings showed severe anemia and thrombocytopenia with a leukocyte count of 3500 per cu. mm. The differential co...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Thrombosis Journal

سال: 2021

ISSN: ['1477-9560']

DOI: https://doi.org/10.1186/s12959-021-00294-7